NEXTCURE, INC.

Profile

Company Names

NEXTCURE, INC.

Addresses

9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD 20705

9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD 20705

13503 SANDERLING PLACE, GERMANTOWN, MD 20874

Phone Numbers

240-399-4900
240-418-1773

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$129,932,873.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-11-12 
$21,500,000.00 
$21,500,000.00 
$0.00 
Equity 
2
2018-11-05 
$93,432,873.00 
$93,432,873.00 
$0.00 
Equity 
1
2015-12-29 
$15,000,000.00 
$67,000,000.00 
$52,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANNE 
 
BORGMAN 
DIRECTOR
NEXTCURE, INC.
STEVEN 
 
COBOURN 
EXECUTIVE OFFICER
NEXTCURE, INC.
STEVEN 
P. 
COBOURN 
EXECUTIVE OFFICER
VACCINEX, INC.   |  NEXTCURE, INC.
ELLEN 
G. 
FEIGAL 
DIRECTOR
NEXTCURE, INC.
CAROLYN 
 
GREEN 
DIRECTOR
LOGICAL THERAPEUTICS INC   |  NEXTCURE, INC.   |  ARRAKIS THERAPEUTICS, INC.
UDAYAN 
 
GUHA 
EXECUTIVE OFFICER
NEXTCURE, INC.
KEVIN 
N. 
HELLER 
EXECUTIVE OFFICER
NEXTCURE, INC.
JOHN 
G. 
HOUSTON 
DIRECTOR
ARVINAS, INC.   |  NEXTCURE, INC.
ELAINE 
 
JONES 
DIRECTOR
AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  FLEXION THERAPEUTICS INC   |  MERSANA THERAPEUTICS, INC.   |  MIRNA THERAPEUTICS, INC.   |  BLADE THERAPEUTICS, INC.   |  NEXTCURE, INC.   |  GRITSTONE BIO, INC.   |  CYTOMX THERAPEUTICS, INC.
ELAINE 
V. 
JONES 
DIRECTOR
CYTOMX THERAPEUTICS, INC.   |  NEXTCURE, INC.
DAVID 
 
KABAKOFF 
DIRECTOR
TRIUS THERAPEUTICS INC   |  ALLYLIX INC.   |  CEBIX INC   |  SOFINNOVA HEALTHQUEST PARTNERS, L.P.   |  LINEAGEN, INC   |  HERA THERAPEUTICS INC.   |  HEALTHQUEST PARTNERS II, L.P.   |  NEXTCURE, INC.   |  BIOTHERANOSTICS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  ANTIVA BIOSCIENCES, INC.   |  BIOCLIN THERAPEUTICS, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  RAINIER THERAPEUTICS, INC.   |  RARECYTE, INC.
CHAU 
Q. 
KHUONG 
DIRECTOR
NEXTCURE, INC.
SOURAV 
 
KUNDU 
EXECUTIVE OFFICER
NEXTCURE, INC.
JUDITH 
 
LI 
DIRECTOR
NEXTCURE, INC.   |  VERITAS GENETICS INTERNATIONAL LTD.   |  E-SCAPE BIO, INC.   |  TMUNITY THERAPEUTICS, INC.   |  INHIBRX, INC.   |  RGENTA THERAPEUTICS, INC.   |  GRITSTONE BIO, INC.   |  ADARX PHARMACEUTICALS, INC.   |  AVENZO THERAPEUTICS, INC.
TIMOTHY 
 
MAYER 
EXECUTIVE OFFICER
NEXTCURE, INC.
MICHAEL 
 
RICHMAN 
EXECUTIVE OFFICER, DIRECTOR
PIERIS PHARMACEUTICALS, INC.   |  NEXTCURE, INC.   |  CAPITAL INTEGRATION SYSTEMS LLC
ASHER 
 
RUBIN 
EXECUTIVE OFFICER
BIG RED SOCIAL CORP.   |  NEXTCURE, INC.   |  DRACEN PHARMACEUTICALS, INC.   |  TAMUROBIO INC.
TIM 
 
SHANNON 
DIRECTOR
NOVIRA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  CYTOMX THERAPEUTICS, INC.   |  VIVACE THERAPEUTICS, INC.   |  SPYRYX BIOSCIENCES, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEXTCURE, INC.   |  HALDA THERAPEUTICS, LLC   |  RALLYBIO HOLDINGS, LLC   |  CAPITAL INTEGRATION SYSTEMS LLC   |  AER THERAPEUTICS, INC.
KEVIN 
 
SHAW 
EXECUTIVE OFFICER
NEXTCURE, INC.
STEPHEN 
 
WEBSTER 
DIRECTOR
AVISTA CAPITAL PARTNERS II, L.P.   |  AVISTA CAPITAL PARTNERS (OFFSHORE) II, L.P.   |  AVISTA CAPITAL PARTNERS III, L.P.   |  AVISTA CAPITAL PARTNERS (OFFSHORE) III, L.P.   |  NABRIVA THERAPEUTICS PLC   |  NEXTCURE, INC.
STELLA 
 
XU 
DIRECTOR
TEMPEST THERAPEUTICS, INC.   |  NEXTCURE, INC.   |  CENTREXION THERAPEUTICS CORP   |  WALKING FISH THERAPEUTICS, INC.
MICHAEL 
 
YI 
DIRECTOR
GOSSAMER BIO, INC.   |  NEXTCURE, INC.   |  OMNIOME, INC.   |  BEAM THERAPEUTICS INC.   |  ALIGOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-10
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2025-11-12 
2018-11-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-05 
2016-01-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375